Singapore markets close in 3 hours 1 minute

Titan Medical Inc. (TMDIF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0363-0.0052 (-12.53%)
At close: 03:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0415
Open0.0390
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0362 - 0.0440
52-week range0.0300 - 0.1800
Volume144,815
Avg. volume109,032
Market cap4.596M
Beta (5Y monthly)N/A
PE ratio (TTM)0.52
EPS (TTM)0.0700
Earnings date08 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Titan Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Extension of 2023 Annual General and Special Meeting

    TORONTO, Ontario, May 29, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that it has entered into an amending agreement dated May 28, 2024 (the “Amending Agreement”), in respect of the previously announced amalgamation agreement dated March 17, 2024 (the “Amalgamation Agreement”) among Conavi Medical Inc. (“Conavi”), 1000824255 Ontario Inc. (a wholly-owned subsidiary of Titan) and Titan, to result in the merger of Conavi and Titan (the “Propos

  • GlobeNewswire

    Titan Provides Update on Planned Merger with Conavi

    TORONTO, Ontario, May 17, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is providing an update on its planned merger with Conavi Medical Inc. (“Conavi”) pursuant to the definitive amalgamation agreement (the “Amalgamation Agreement”) dated March 17, 2024 (the “Transaction”), as previously announced on March 18, 2024 and April 22, 2024. Titan and Conavi are both working on satisfying the closing conditions outlined in the Amalgamation Agreement, which includes: Prep

  • GlobeNewswire

    Titan Medical Reports Financial Results for the First Quarter 2024

    TORONTO, Ontario, May 13, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the three months ended March 31, 2024. Recent Activities: On March 18, 2024, the Company announced it has entered into a definitive amalgamation agreement (the “Definitive Agreement”) with Conavi Medical Inc. (“Conavi”) to combine the companies in an all-stock transaction (the “Transaction”). Under the terms of the Definitive Agreement, a n